Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence | NCT00693420 | Trialant
CompletedInterventionalPhase 3Updated Oct 30, 2013
Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence
ClinicalTrials.gov ID
NCT00693420
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 3
Enrollment
278Actual
Last Update Posted
Oct 30, 2013Estimated
Start Date
Apr 2007
Primary Completion Date
Oct 2007Actual
Completion Date
Dec 2007Actual
Brief Summary
This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.
Eyelashes
Bimatoprost 0.03% sterile solution
vehicle sterile solution
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Dissatisfaction with eyelash prominence,
Eyelash prominence assessment of minimal or moderate,
Ability to provide written informed consent
Exclusion Criteria:
Subjects without visible lashes,
Asymmetrical (uneven lashes or longer on one side than the other) eyelashes,
Any eye disease or abnormality,
Eye surgery,
Permanent eyeliner,
Eyelash implants,
Eyelash extension application,
Any use of eyelash growth products within 6 months of study entry,
Treatments that may effect hair growth,
Subjects requiring eye drop medications for glaucoma,
Subjects having a situation or condition, which the study doctor feels might put you at risk, may make the study results confusing, or may interfere with the study.